IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $68 | – | 193 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 193 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 193 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 193 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 193 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 193 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 193 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 193 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 193 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | – | 193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 629,340 | $5,607,000 | 0.82% |
| Baker Brothers Advisors | 4,833,897 | $43,070,000 | 0.28% |
| Kassirer Asset Management Corp | 19,341 | $172,000 | 0.11% |
| Virtus ETF Advisers LLC | 34,596 | $308,000 | 0.03% |
| Palo Alto Investors LP | 77,044 | $686,000 | 0.03% |
| ROPES WEALTH ADVISORS LLC | 12,500 | $111,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 147,560 | $1,280,000 | 0.03% |
| Candriam S.C.A. | 195,000 | $1,737,000 | 0.02% |
| NATIXIS | 429,816 | $3,830,000 | 0.02% |
| Cordasco Financial Network | 1,875 | $17,000 | 0.02% |